Summit Therapeutics Inc.
Status: Publicly traded
Direct answer
Summit Therapeutics Inc. is publicly traded on NASDAQ under the ticker SMMT.
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered...
Can you invest in Summit Therapeutics Inc.?
Yes. Summit Therapeutics Inc. trades publicly on NASDAQ as SMMT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Summit Therapeutics Inc.
Detailed equity research is provided by MarketSnap.